Lantern Pharma Inc. (LTRN) Form 8-K — May 14, 2026
$LTRNForm 8-KItems 1.01, 3.02, 8.01, 9.01Filed May 14, 2026, 8:00 AM ET0001493152-26-023200Original filing
Lantern Pharma Inc. (LTRN) closed a registered direct offering on May 14, 2026, raising approximately $4.4 million in gross proceeds. The company issued 1,454,175 shares of common stock at $2.06 per share and 681,748 pre-funded warrants at $2.0599 per warrant to institutional investors. In a concurrent private placement, Lantern issued warrants to purchase up to 2,135,923 shares of common stock at an exercise price of $2.27 per share.
Key figures
- Gross Proceeds
- 4400000
- Offering Price
- 2.06
- Shares Offered
- 1454175
- Purchase warrants
- 2135923
- Pre funded warrants
- 681748
- Pre funded warrant price
- 2.0599
- Placement agent fee percent
- 7
- Purchase warrant exercise price
- 2.27
- Placement agent warrant exercise price
- 2.575
Price after filing
1 day: 0.0%7 days: +6.1%30 days: +30.0%
Close on the filing date to close N calendar days later (from $3.13). Historical, not a forecast.
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.